Consumer preferences among pharmacy needle exchange attenders

Pharmaceutical Journal

Volumn 261, Issue 7002, 1998, Pages 4-6

  Clarke, Kim ^a   Sheridan, Janie ^b   Williamson, Sara ^b   Griffiths, Paul ^b  

^a Lewisbam Guy's Mental Hlth NHS T   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2442481997     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Department of Health. The task force to review services for drug misusers: report of an independent review of drug treatment services in England. London: HM Stationery Office, 1996.
2. Advisory Council on the Misuse of Drugs. AIDS and drug misuse: update report. London: HM Stationery Office, 1993.
3. Stimson GV. AIDS and injecting drug use in the United Kingdom 1987-1993: the policy response and the prevention of the epidemic. Soc Sci Med 1995;41:699-716.
4. Majid A. Holmes R, Dresselberger U, et al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users in rural communities. J Med Virol 1995;46:48-51.
5. Stimson G, Has the United Kingdom averted an epidemic of HTV-1 infection among drug injectors? Addiction 1996;91:1085-8.
6. Anthony R, Shorrock PJ, Christie MM. Pharmacy-based needle and syringe exchange schemes. An evaluation within Trent region. Leicester: Nepenthe, 1995.
7. British Liver Trust. Injecting drug use and hepatitis C. Ipswich: The Trust, 1997.
8. Gossop M, et al. Continuing drug risk behaviour: shared use of injecting paraphernalia. Aids Care 1997;9:651-60.
9. Waller T, Holmes R. Hepatitis C: scale and impact in Britain. Druglink 1995;Sept/Oct:8-11.